{"disease":{"id":"femoropopliteal-occlusive-disease","name":"femoropopliteal occlusive disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04698304","title":"The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT03414515","title":"Endovascular Treatment of Peripheral Artery Disease (PAD)","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Duomed","has_results":false},{"nct_id":"NCT03346577","title":"Endovascular Treatment of Peripheral Artery Disease","phase":"","overall_status":"TERMINATED","enrollment_count":60,"lead_sponsor_name":"be Medical","has_results":false},{"nct_id":"NCT02939924","title":"Treatment of Patients With Lesions in the Superficial Femoral and/ or Popliteal Arteries Using Kanshas Paclitaxel-coated Balloon Catheter.","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Terumo Europe N.V.","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}